Drug development research for novel adiponectin receptor-targeted antidiabetic drugs contributing to healthy longevity

scientific article published on 19 September 2019

Drug development research for novel adiponectin receptor-targeted antidiabetic drugs contributing to healthy longevity is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1007/S13340-019-00409-6
P932PMC publication ID6763548
P698PubMed publication ID31592400

P2093author name stringTakashi Kadowaki
Masato Iwabu
Miki Okada-Iwabu
Toshimasa Yamauchi
P2860cites workPositional cloning of the mouse obese gene and its human homologueQ22251285
Cloning of adiponectin receptors that mediate antidiabetic metabolic effectsQ24304889
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinaseQ24309462
mTOR signaling in growth control and diseaseQ24634174
Caloric restriction delays disease onset and mortality in rhesus monkeysQ24655994
Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participantsQ26749640
Perspective of Small-Molecule AdipoR Agonist for Type 2 Diabetes and Short Life in ObesityQ26777180
A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesisQ27860471
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylaseQ27860668
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin ResistanceQ28131660
Endogenous glucose production is inhibited by the adipose-derived protein Acrp30Q28366672
The adipocyte-secreted protein Acrp30 enhances hepatic insulin actionQ28505765
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesityQ28506782
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30Q28511676
Increased beta -oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectinQ28588020
Disruption of adiponectin causes insulin resistance and neointimal formationQ28589597
A Novel Serum Protein Similar to C1q, Produced Exclusively in AdipocytesQ28590335
Extension of murine life span by overexpression of catalase targeted to mitochondriaQ29614546
Paradoxical decrease of an adipose-specific protein, adiponectin, in obesityQ29616103
AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolismQ29617261
Obesity and the regulation of energy balanceQ30080025
Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: role of tumor necrosis factor-{alpha}.Q33736175
Adiponectin/adiponectin receptor in disease and agingQ33914270
Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in miceQ34118282
The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation.Q34249837
cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).Q34377772
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesityQ34381237
Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activationQ34416242
Lifespan extension induced by AMPK and calcineurin is mediated by CRTC-1 and CREBQ34995412
Expression, purification, crystallization, and preliminary X-ray crystallographic studies of the human adiponectin receptors, AdipoR1 and AdipoR2Q35085549
Minireview: The adipocyte--at the crossroads of energy homeostasis, inflammation, and atherosclerosisQ35204725
Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolismQ35641736
Adiponectin and atherosclerotic diseaseQ35776566
Adipose tissue, inflammation, and cardiovascular diseaseQ36125401
Endocrine and signalling role of adipose tissue: new perspectives on fat.Q36199000
Insulin resistance and coronary heart disease in nondiabetic individualsQ38027824
Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonistsQ38318111
Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosisQ38361016
Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1.Q39720264
Crystal structures of the human adiponectin receptorsQ41099333
Structural insights into adiponectin receptors suggest ceramidase activity.Q41232999
Pathophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experienceQ41457773
Multiple regulatory roles of a novel Saccharomyces cerevisiae protein, encoded by YOL002c, in lipid and phosphate metabolismQ42673088
AdipoQ is a novel adipose-specific gene dysregulated in obesityQ42813232
Extension of Drosophila lifespan by overexpression of human SOD1 in motorneuronsQ47991847
Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster.Q52543010
Structure and function analysis of adiponectin receptors toward development of novel antidiabetic agents promoting healthy longevityQ57036110
Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actionsQ57249776
Adiponectin reduces atherosclerosis in apolipoprotein E-deficient miceQ64378290
Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axisQ64378601
Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasmaQ71842674
Triglycerides and toggling the tummyQ73765862
The humoral side of insulin resistanceQ82194854
P433issue4
P304page(s)237-244
P577publication date2019-09-19
P1433published inDiabetology internationalQ27727408
P1476titleDrug development research for novel adiponectin receptor-targeted antidiabetic drugs contributing to healthy longevity
P478volume10

Search more.